Rheumatoid arthritis and ocular myasthenia gravis: Effectiveness of rituximab in the management of these two diseases
Reumatol Clin (Engl Ed). 2018 May-Jun;14(3):179-180.
doi: 10.1016/j.reuma.2017.05.006.
Epub 2017 Jun 16.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Reumatología, Hospital Clínico Universitario San Cecilio, Granada, España. Electronic address: mnovellanavarro@gmail.com.
- 2 Servicio de Reumatología, Hospital Clínico Universitario San Cecilio, Granada, España.
No abstract available
MeSH terms
-
Aged
-
Antirheumatic Agents / adverse effects
-
Antirheumatic Agents / therapeutic use
-
Arthritis, Rheumatoid / complications
-
Arthritis, Rheumatoid / drug therapy*
-
Arthritis, Rheumatoid / immunology
-
Drug Substitution
-
Etanercept / adverse effects
-
Etanercept / therapeutic use
-
Female
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Myasthenia Gravis / chemically induced
-
Myasthenia Gravis / complications
-
Myasthenia Gravis / drug therapy*
-
Myasthenia Gravis / immunology
-
Prednisone / therapeutic use
-
Remission Induction
-
Rituximab / therapeutic use*
Substances
-
Antirheumatic Agents
-
Immunosuppressive Agents
-
Rituximab
-
Etanercept
-
Prednisone